PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20455087-3	2010	Both retinoic acid (RA) and arsenic trioxide directly target PML/RARA-mediated transcriptional repression and protein stability, inducing rapid differentiation of the promyelocytes and clinical remission in most APL patients.	Tretinoin	5-18	PML nuclear body scaffold	Homo sapiens	61-64	
20455087-3	2010	Both retinoic acid (RA) and arsenic trioxide directly target PML/RARA-mediated transcriptional repression and protein stability, inducing rapid differentiation of the promyelocytes and clinical remission in most APL patients.	Tretinoin	20-22	PML nuclear body scaffold	Homo sapiens	61-64